Baldwin Brothers LLC Eli Lilly & CO Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Baldwin Brothers LLC holds 2,111 shares of LLY stock, worth $1.62 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,111

Previous 1,265 66.88%

Holding current value

$1.62 Million

Previous $1.15 Million 63.32%

% of portfolio

0.13%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $653,230 - $812,176	846 Added 66.88%	2,111 $1.87 Million
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $10,148 - $12,726	14 Added 1.12%	1,265 $1.15 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $12,436 - $16,637	-21 Reduced 1.65%	1,251 $973,000
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $8,768 - $11,724	-25 Reduced 1.93%	1,272 $596,000
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $12,425 - $14,592	-40 Reduced 2.99%	1,297 $445,000
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $142,768 - $166,353	444 Added 49.72%	1,337 $0
Q4 2021 Jan 14, 2022	BUY	$224.85 - $279.04 $16,863 - $20,928	75 Added 9.17%	893 $247,000
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $29,251 - $35,997	-132 Reduced 13.89%	818 $189,000
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $7,763 - $10,042	-43 Reduced 4.33%	950 $218,000
Q1 2020 Apr 15, 2020	SELL	$119.05 - $147.35 $48,453 - $59,971	-407 Reduced 29.07%	993 $138,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $155,834 - $183,428	1,400 New	1,400 $182,000
Q2 2018 Jul 24, 2018	SELL	$75.7 - $86.88 $259,802 - $298,172	-3,432 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $264,504 - $293,573	3,432	3,432 $294,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Eli Lilly & CO Transaction History